Consonance Capital Partners closed Consonance Private Equity III with $1.35 billion in commitments, reaching the fund’s hard cap in less than four months.
The fundraising process was heavily oversubscribed, reflecting strong demand from both existing and new limited partners.
Fund III will continue Consonance Capital Partners’ strategy of investing in lower- and middle-market healthcare companies across the United States.
The fund will target businesses that can improve efficiency, reduce costs, and support high-quality patient care.
Consonance said Fund III received strong support from its existing limited partners while also adding a select group of new investors.
The investor group includes endowments and foundations, pension plans, financial institutions, and other institutional investors worldwide.
The close gives Consonance additional capital to pursue growth equity, leveraged buyout, carve-out, recapitalization, and special situation opportunities across the U.S. healthcare sector.
The firm said it remains focused on partnering with management teams building businesses that can create sustainable value across the healthcare system.
Consonance Capital Partners specializes in private healthcare investments and emphasizes companies positioned around efficiency, cost containment, and quality of care.
Support: Monument Group served as global placement agent for Fund III. Latham & Watkins LLP served as legal counsel.
KEY QUOTE:
“We are thrilled to close Fund III at its hard cap and want to thank our limited partners for their tremendous support. We also want to thank the management teams of our existing and previous portfolio companies who have been steadfast partners and major contributors to these results. We completed fundraising at a pace that reflects the confidence investors have placed in our team, strategy and results and the strength of our existing relationships. Our team remains highly focused and disciplined as we continue to partner with world-class management teams building businesses that add sustainable value to the healthcare system via a commitment to high-quality, cost-effective care.”
Managing Partners of Consonance Capital Partners
